Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three-year open-label atorvastatin study in children and adolescents with heterozygous familial hypercholesterolemia
2008-006130-95Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of atorvastatin in heterozygous familial hypercholesterolemia (HeFH), sponsored by Pfizer. Primary endpoints: Low-density lipoprotein cholesterol, Total cholesterol and 5 more. Started Feb 2009; status: completed.
02
Drugs
atorvastatin
03
Conditions
heterozygous familial hypercholesterolemia (HeFH)
Beyond the preview
Go deeper on 2008-006130-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006130-95.